CHI HEALTH LAKESIDE
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $490K
- Transactions
- 55
- Companies
- 10
- Average per transaction
- $8,911
Who reported the payments
| Boston Scientific | $318,966 |
| AstraZeneca | $67,950 |
| Intercept Pharmaceuticals, Inc. | $65,206 |
| Abbott | $17,752 |
| Akebia Therapeutics Inc | $7,397 |
| Novartis | $6,121 |
| Novocure Inc. | $3,000 |
| Takeda Pharmaceuticals U.S.A., Inc. | $2,271 |
| Biotronik Inc. | $1,033 |
| Acerta Pharma LLC | $400 |